September 16, 2023

The FDA ap­proved a new JAK in­hibitor, mo­melo­tinib, from GSK for adults with the rare bone mar­row can­cer myelofi­bro­sis who al­so have ane­mia. The ap­proval

Lawyers from the De­part­ment of Jus­tice and US Cham­ber of Com­merce bat­tled be­fore an Ohio dis­trict court judge over whether the Cham­ber’s law­suit over the

Lyn­dra Ther­a­peu­tics is let­ting go about 23% of its work­force as the Boston-area biotech seeks to trim op­er­a­tional costs ahead of a piv­otal tri­al read­out

No­var­tis’ San­doz spin­off is right on track fol­low­ing a share­hold­er vote in fa­vor of a full sep­a­ra­tion on Fri­day. The gener­ics and biosim­i­lars unit is